View Online
September 19, 2019
News From Medscape
The following recommended articles on are freely available through the partnership between ABC and Medscape, no registration or login required.
Vintage ICD Trials in Heart Failure Upheld by Contemporary Registry Data
The survival benefits of primary-prevention device therapy seen in seminal trials reported in the early 2000s still apply today, suggests a registry study from Sweden that also saw gross implantable cardioverter-defibrillator (ICD) underuse in its sample of eligible patients.
SYNTAXES: CABG for Best 10-Year Survival in Multivessel Disease
Among patients with complex coronary artery disease (CAD) who required de novo revascularization, those with three-vessel disease had better 10-year survival after coronary artery bypass grafting (CABG) than after percutaneous coronary intervention (PCI).
HOPE 4: Hypertension Screening in Community Reduces CV Risk
A community-based initiative, in which nonphysician healthcare workers screened individuals for hypertension in their own homes and community centers in two middle-income countries, resulted in a substantial reduction in cardiovascular disease risk, primarily through improvements in blood pressure, low-density lipoprotein (LDL) cholesterol, medication adherence, and some health behaviors in the HOPE 4 study.
Items of Interest
Translational Research: Diet Affects the Heart in Multiple Ways
It's not just the actual food eaten, but also the timing and potential effects of inflammation that matter in diet‐induced cardiac dysfunction, translational research is showing.
Latinos at High Risk For "Food Insecurity," Leading to Type 2 Diabetes
The research by UConn School of Medicine, UConn School of Dental Medicine, Yale School of Public Health, Quinnipiac University, Hartford Hospital, and the Hispanic Health Council, suggests that for Latinos with type 2 diabetes food insecurity is linked to the disease’s development and progression.
New Studies Focus on How to Improve Food Access for Diabetic African Americans in Milwaukee
With a more than $3.2 million, five-year grant from the National Institutes of Health Institute on Minority Health and Disparities, Leonard Egede, MD, MS, professor of medicine and chief of the Division of General Internal Medicine, and Rebekah Walker, PhD, assistant professor of medicine at MCW, will test the separate and combined efficacy of monthly food vouchers for farmer’s markets and monthly mailed food stock boxes layered upon diabetes education for low income, food insecure African Americans with Type 2 diabetes.
Healthy Plant-Based Diet Lowers Risk For CVD Mortality, Morbidity
According to a study published in the Journal of the American Heart Association, a general population of middle-aged adults without CVD at baseline who ate more plant-based foods and less animal products had a lower risk for incident CVD, CVD mortality and all-cause mortality during a median follow-up of 25 years.
Caution: Sleeping Too Little — or Too Much — Boosts Heart Attack Risk
Even if you are a non-smoker who exercises and has no genetic predisposition to cardiovascular disease, skimping on sleep—or getting too much of it—can boost your risk of heart attack, according to a new CU Boulder study of nearly a half-million people. The research, published in the Journal of the American College of Cardiology, also found that for those at high genetic risk for heart attack, sleeping between 6 and 9 hours nightly can offset that risk.
FDA Grants Fast Track Designation for FARXIGA in Heart Failure
Astrazeneca today announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of FARXIGA (dapagliflozin) to reduce the risk of cardiovascular (CV) death or worsening of heart failure in adults with heart failure with reduced ejection fraction (HFrEF) or preserved ejection fraction (HFpEF). The FDA’s Fast Track program is designed to accelerate the development and review of new medicines for the treatment of serious conditions where there is unmet treatment need.
Penn Doctor Says Gun Control, Climate Change Don't Belong in Med School; Critics Lash Back
Politics and social justice should not be part of medical school according to the former associate dean of curriculum at the University of Pennsylvania’s Perelman School of Medicine. Stanley Goldfarb, a kidney specialist and longtime faculty member at Penn, made his case in a Wall Street Journal column, saying that med schools should not spend time on gun violence, climate change, and “other progressive causes only tangentially related to treating illness.”
Opinion: Social Justice Is the Foundation of Healthcare — And Medical Education
Dr. Stanley Goldfarb, our medical school colleague at the University of Pennsylvania, published an essay in the Wall Street Journal last week arguing for a return to “the traditional American model of medical training.” He laments a move toward greater emphasis on social justice, health policy, and population health, with a “focus on climate change, social inequalities, gun violence, bias and other progressive causes only tangentially related to treating illness.” Yet, it is well established, for example, that bias in medicine has led to under-diagnosis of heart attacks in women, to under-treatment of depression in black patients, and to difficulty scheduling primary care appointments for low-income patients covered by Medicaid.
[First Opinion] A Dangerous View: Why It's a Mistake For Medical Schools to Ignore Social Justice
The recent essay in the Wall Street Journal by Dr. Stanley Goldfarb, former dean of curriculum at Perelman, is both disheartening and dangerous. Goldfarb suggests that medical education is focusing too much on social justice issues “rather than treating illness.” the reality is that in seeing patients, physicians grapple with unemployment, housing instability, and food access; systemic racism, sexism, and LGBTQ rights; immigration reform, climate change, and violence. All of these issues profoundly — not tangentially — affect our patients’ health.
Is Your Physician Colleague At Risk For Suicide? Signs to Look For
Two-thirds of people who attempt suicide do so after having seen a physician within the previous month. It’s a strong statement about the importance of being alert for telltale signals. That extends to high-risk individuals who aren’t patients, but who many physicians see every day—their colleagues. Recently released CME covering suicide screening and prevention for patients also addresses what physicians should look for among their colleagues—and themselves—to reduce the chances of suicide. The CME video, “Identifying and Responding to Suicide Risk,” is designated by the AMA for one AMA PRA Category 1 Credit™.

September is National Suicide Prevention Awareness Month
Featured Articles by Members
ABC Members: We welcome your published research submissions and articles for inclusion in future issues of Clinical Updates and Insights. Email Rachel Williams at and please attach file or include links to the original published work and/or abstract.
Successful Implementation of Healthful Nutrition Initiatives into Hospitals
Co-authored by Eugenia Gianos, Columbus Batiste and Kim Williams (with Monica Aggarwal, Ariel Grady, Daya Desai, Katrina Hartog, Lilian Correa, Robert J. Ostfeld, et al.)
Poor dietary quality is a leading contributor to mortality in the United States and to most cardiovascular risk factors. By providing education on lifestyle changes and specifically, dietary changes, hospitals have the opportunity to use the patient experience as a “teachable moment.” The food options provided to inpatients and outpatients can be a paradigm for patients to follow upon discharge from the hospital. There are hospitals in the United States that are showcasing novel ways to increase awareness of optimal dietary patterns and can serve as a model for hospitals nationwide.
A Defined, Plant-Based Diet As a Potential Therapeutic Approach in the Treatment of Heart Failure: A Clinical Case Series
Co-authored by Baxter D. Montgomery (with Rami S. Najjara)
Individuals diagnosed with congestive heart failure (CHF) have a 50% five-year mortality rate and approximately 650,000 new cases of CHF are diagnosed annually. Plant-based diets are known to improve plasma lipid concentrations, reduce blood pressure, and as part of a lifestyle intervention, lead to the regression of atherosclerotic lesions. However, a paucity of data exists with regards to plant-based diets in the treatment of CHF.
Sleep Debt: The Impact of Weekday Sleep Deprivation On Cardiovascular Health in Older Women
Co-authored by Michelle A. Albert (with Tomás Cabeza de Baca, Koharu Loulou Chayama, Susan Redline, Natalie Slopen, Fumika Matsushita, Aric A Prather, David R Williams, Julie E Buring, and Alan M Zaslavsky)
Short sleep duration is associated with increased cardiovascular disease (CVD) risk. However, it is uncertain whether sleep debt, a measure of sleep deficiency during the week compared to the weekend, confers increased cardiovascular risk. Because sleep disturbances increases with age, particularly in women, we examined the relationship between sleep debt and ideal cardiovascular health (ICH) in older women.
Heart Failure Burden Increasing for Black Adults in the U.S.
A new analysis suggests that the total burden of heart failure is increasing, and that disparities between black and white adults persist. The study researchers, presented at the Heart Failure Society of America and published in the meeting supplement of the Journal of Cardiac Failure, included over 20,000 participants who identified as non-Hispanic black or white from the National Health and Nutrition Examination Survey (NHANES) between 1999 and 2016.
Elizabeth Ofili, MD: Heart Failure Outreach
A special session at this year’s Heart Failure Society of America (HFSA) 2019 Scientific Sessions featured a presentation and discussion with Elizabeth Ofili, MD and Shaquille O’Neal, EdD, who spoke about disparities in heart failure rates among African Americans and how to better serve that population. After the presentation Ofili, who is the first female president of the Association of Black Cardiologists, sat down with MD Magazine® to discuss the importance of annual conferences such as HFSA 2019 for outreach and engagement.
Q&A: Shaq Gets Real About HF Awareness in Black Population
Shaquille O’Neal, PhD, FHFSA, retired basketball star and winner of four NBA championships, discussed the recently launched campaign Shaq Gets Real, which focuses on raising awareness about HF in the black population and providing support for improved access to medication and treatment, at the Heart Failure Society of America Scientific Meeting. Joining O’Neal, Elizabeth Ofili, MD, MPH, FACC, past president, chair-elect and board member of the Association of Black Cardiologists, highlighted many of the existing disparities that put African Americans at a higher risk of HF. Healio spoke with O’Neal and Ofili regarding their joint efforts to inform black individuals about HF and to minimize racial disparities in prevalence and treatment of HF.
DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF
Like DAPA-HF, this much smaller trial confirms the ability of an SGLT2 inhibitor to confer symptom improvement over time. Dapagliflozin added to optimal medical therapy results in meaningful improvements in symptoms and health-related quality of life in heart failure patients with reduced ejection fraction (HFrEF), the results of the DEFINE-HF trial show. However, the sodium glucose co-transporter-2 (SGLT2) inhibitor did not reduce levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP) compared with placebo.
James Januzzi, MD: The PROVE-HF Trial
In new data from the PROVE-HF trial presented at the Heart Failure Society of America (HFSA) 2019 Scientific Sessions in Philadelphia, PA, sacubitril/valsartan (Entresto) was shown to benefit patients with reduced ejection fraction heart failure (HFrEF), regardless of dosing titration, over 1 year. The findings, which included patients from PARADIGM-HF as well as those who did not qualify, changes the scope of understanding as to how the angiotensin receptor/neprilysin inhibitor therapy affects patients.
Debate: Is LVEF Really That Important in Heart Failure?
Left ventricular ejection fraction (LVEF or EF) was in the hot seat during a debate at the Heart Failure Society of America (HFSA) annual meeting, in which Gregg Fonarow, MD, argued in favor of LVEF as essential for the diagnosis of HF and its treatment by guideline-directed medical and device therapy.
Highlights of ASNC 2019
Learn about key moments at the recent Annual Scientific Session of American Society of Nuclear Cardiology (ASNC), including a session with Clyde W. Yancy, MD, who outlined practical approaches to tackling disparities in cardiovascular disease during an opening keynote address.
ASNC Releases Multisocietal Cardiac Amyloidosis Imaging Guidelines
The American Society of Nuclear Cardiology (ASNC) has published a new expert consensus document along with eight other nuclear medicine and cardiology societies - consisting of 26 experts - on best practices for multimodality imaging and diagnosing cardiac amyloidosis in the Journal of Nuclear Cardiology. Newer imaging methods have facilitated earlier diagnosis of the disease and improved treatments, but those advancements haven’t been reflected in the medical literature. Watch a video of the guidelines.

We LOVE to LEARN how our ABC Members are making a difference! Please Share. Giving a keynote speech? Presenting at a Grand Round? Receiving an Award? Interviewed by the Press? Published in a journal? Presenter or Panelist at a Conference? Graduating? Email Rachel Williams at or please tag or DM us on Facebook, Twitter or Instagram with links/details, so we can spotlight your excellence in our newsletter!

High-visibility sponsorship opportunities are available.
Contact us at or visit us at

Policy Pulse
Dinner Program

Fri, Oct 11 2019
6:00 PM PST

InterContinental Los
Angeles Downtown

Fall Symposium
“Current Trends in Cardiovascular and Cardio-metabolic Disease Prevention, and Updates in Cardiac Devices and Advanced Cardiac Failure”

Sat, Oct 12 2019
8:00 AM - 1:00 PM PST

InterContinental Los
Angeles Downtown

10th Annual Spirit of the Heart Awards Program & Fundraiser

Sat, Oct 12 2019
6:00 PM PST

InterContinental Los
Angeles Downtown



InterContinental Los Angeles Downtown
900 Wilshire Blvd
Los Angeles, CA 90017

ABC Member CME Event
UCSF Division of Cardiology at Zuckerberg San Francisco
General Hospital and Trauma Center Seeks Chief

The University of California San Francisco (UCSF) Department of Medicine at Zuckerberg San Francisco General Hospital and Trauma Center (ZSFG) seeks an outstanding leader for its Division of Cardiology. The Division is comprised of 15 MD faculty, 2 PhD faculty and clinical/research staff.

The position is for a Chief who has a demonstrated commitment to science, education and clinical practice, the ability to lead a diverse group and work with hospital partners using a collaborative approach, success in promoting or producing scholarship and funding, and the ability to mentor young academic clinicians. Successful candidates must demonstrate exceptional leadership, administrative and organizational skills and have national stature in academic Cardiology. Board-certification in Cardiology is required. An understanding of and commitment to the safety net population is also crucial.


ABIM Calling for Board and Committee Nominations

Help Shape the Future of Board Certification. Please consider nominating a colleague or applying yourself to join an ABIM board or committee.

The Cardiovascular Board for the American Board of Internal Medicine (ABIM) is seeking four new member(s) for the Specialty Board next year. Priorities for candidates are an adult congenital heart disease physician, allied health professional with deep expertise in cardiology, a general cardiologist with experience in a large academic or non-academic healthcare system and an interventional cardiologist.

The submission deadline has been extended to September 30, 2019.


NHLBI Seeking exceptional candidates. Scientific excellence. Passion for leading change & leading people.
Send CV to


September is PAD Awareness Month!

Today, nearly 20 million Americans are living with peripheral artery disease (PAD) and an estimated 200,000 of them – disproportionately from minorities communities – suffer avoidable amputations every year.

Fortunately, lawmakers in Congress are taking action. Representatives Donald M. Payne, Jr. (D-NJ-10) and Gus Bilirakis (R-FL-12) have worked together to establish the first Congressional PAD Caucus to educate Congress and communities about PAD while supporting legislative activities to improve PAD research, education, and treatment, with the goal of preventing non-traumatic amputations due to PAD and other related diseases.

In honor of PAD Awareness Month, ask your Member of Congress to raise #PADAwareness by becoming a member of the Congressional PAD Caucus.


Upcoming Events



Through our partnership with CMHC and mutually aligned goals, we are offering an exclusive discount to our network. Insert coupon code ABC19 to save $100 on your registration!

Register for ABC @ AHA Events

Saturday, November 16th | Philadelphia Marriott Downtown
1201 Market Street, Philadelphia, PA 19107

‘A New Beat’ Reception | 5:15pm – 6:00pm
ABC General Membership Dinner Meeting | 6:00pm – 7:00pm
ABC Dr. Walter M. Booker, Sr. Memorial Symposium | 7:00pm – 9:00pm
“Navigating and Translating Guideline Directed Therapies and Interventions to Real-World Management of Cardiovascular Disease:
A Case Based Analysis of Therapeutic Conundrums”

Co-Chairs: John M. Fontaine, MD, MBA & Gerald DeVaughn, MD


ABC Job Opening | Certified Clinical Research Coordinator

The Association of Black Cardiologists (ABC), is a nonprofit organization whose mission is to reduce the burden of cardiovascular disease among minority populations and abolish disparities in healthcare outcomes in all people of color with a particular emphasis on the African-American population. The ABC is actively involved in research and seeks to hire a certified clinical research coordinator who will avidly engage in the broad breadth of research activities that are underway and under consideration at the ABC. This individual will work under the supervision of ABC investigators, Research Committee Chair, and the Chief Science Officer.

The research coordinator must be familiar with the various aspects of study design, clinical trial operations, study site management, data management and informatics. Additionally, it is expected that the individual will be familiar with ethical and safety aspects involved in conducting research, examining and submitting protocols to institutional review boards, assisting in writing protocols and also will be a liaison and major advocate in enhancing the participation of underrepresented minorities in the research endeavor. Qualifications entail a bachelor’s degree (Master’s preferred) and certification as a clinical research coordinator.

To apply for this opportunity, please send resume, cover letter
and salary requirements to

This email was sent to ##email## by Association of Black Cardiologists, powered by Powered by Multiview's Content Marketing
Engage your customer base. Launch your Content Marketing program today.
Archive | View Online | Unsubscribe | Subscribe